Biomerica, Inc.

NASDAQ:BMRA

0.35 (USD) • At close September 6, 2024
Bedrijfsnaam Biomerica, Inc.
Symbool BMRA
Munteenheid USD
Prijs 0.347
Beurswaarde 5,837,095
Dividendpercentage 0%
52-weken bereik 0.24 - 2.13
Industrie Medical Devices
Sector Healthcare
CEO Mr. Zackary S. Irani
Website https://www.biomerica.com

An error occurred while fetching data.

Over Biomerica, Inc.

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other

Vergelijkbare Aandelen

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

7.81 USD

Oncternal Therapeutics, Inc. logo

Oncternal Therapeutics, Inc.

ONCT

3.98 USD

Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc.

CRBP

50.04 USD

Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc.

TPST

1.24 USD

AVROBIO, Inc. logo

AVROBIO, Inc.

AVRO

1.4 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)